- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Research Feature
Last year as the COVID-19 pandemic began to intensify, many patients with the debilitating genetic disease, cystic fibrosis, faced a difficult challenge. Because the disease damages the lungs and makes it hard to breathe, these patients needed in-hospital tests to measure how well their lungs were working. But many also were on drugs that reduce...
Showing 10 out of 329 results
|
Statement
On World Asthma Day, the National Institutes of Health reaffirms its commitment to research to improve the lives of people with asthma. More than 25 million people in the United States have asthma , including 5.1 million children, according to the Centers for Disease Control and Prevention. This chronic lung disease can reduce quality of life,...
|
News Release
Los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) han autorizado $29 millones de dólares en subvenciones adicionales para la Coalición “Alianza de Participación Comunitaria (CEAL, por sus siglas en inglés) de NIH contra las disparidades del COVID-19”. Esta financiación , parte del Plan de Rescate Estadounidense, esta dirigida a...
|
News Release
To bolster research to help communities disproportionately affected by COVID-19, the National Institutes of Health is funding $29 million in additional grants for the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities. This funding was supported by the American Rescue Plan. The awards will provide $15 million to 11 teams already...
|
News Release
African Americans who smoke appear to have more than twice the risk of developing coronary heart disease compared to those who do not smoke, a new study has found. The findings—the first up-close look at the relationship between smoking and coronary heart disease in this population—also examined the risk for plaque buildup in the arteries of...
|
Statement
The National Institutes of Health (NIH) has launched the last of three Phase 3 clinical trials to evaluate the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults diagnosed with COVID-19. The first patient in the trial was enrolled on February 15. Part of the Accelerating COVID-19 Therapeutic Interventions...
|
News Release
Finding could lead to new ways to reduce complications from painful red blood cell disorder Researchers have discovered that DNA from the mitochondria - the cell’s “powerhouses” - acts as a danger signal in the body and triggers inflammation in people with sickle cell disease. A better understanding of mitochondrial DNA, long known to circulate in...
|
Media Advisory
Study shows the treatment is safe, but provides no significant benefit in this group What: The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to moderate symptoms of COVID-19, the disease caused by the...
|
News Release
Study identifies cardiovascular risk factors that may lead to pregnancy problems for first-time moms
NIH-supported findings also show cardiovascular risks and pregnancy complications can raise chances of hypertension years after childbirth A new study of first-time pregnant women found risk factors for heart disease, such as obesity and elevated blood sugar, can put expectant moms at higher risk for pregnancy complications and gestational diabetes...
|
Media Availability
Historic findings could boost precision medicine, reduce health disparities WHAT: Researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, announced the publication of a groundbreaking study which analyzed more than 53,000 whole genomes, primarily from minority populations. The study...
|
Media Availability
WHAT: This February, during American Heart Month , experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss the latest science on COVID-19 and heart disease, as well as treatment, risk factors, and lifestyle changes to support cardiovascular health. They will also highlight the importance of preventive measures to...